NAN FUNG TRINITY (HK) Ltd BCAX — BICARA THERAPEUTICS INC

Ownership history in NAN FUNG TRINITY (HK) Ltd  ·  4 quarters on record

AI Ownership Summary

NAN FUNG TRINITY (HK) Ltd reported BICARA THERAPEUTICS INC (BCAX) in 4 quarterly 13F filings from 2025 Q2 through 2026 Q1. Peak portfolio weight reached 0.93% in 2026 Q1. The latest visible filing shows BCAX at 0.93% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this BCAX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was NAN FUNG TRINITY (HK) Ltd's position in BICARA THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

BCAX was reported at 0.93% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.93% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

BCAX stock page NAN FUNG TRINITY (HK) Ltd fund profile NAN FUNG TRINITY (HK) Ltd full holdings
How NAN FUNG TRINITY (HK) Ltd held BCAX — position size vs. price
% of Fund (quarterly)    BCAX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 4 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED — — — 427,885 +55,500 +14.9% 0.93% $8.5M 2026-05-05 $23.16
2025 Q4 REDUCED — — — 372,385 -12,500 -3.2% 0.50% $6.3M 2026-02-04 $16.37
2025 Q3 ADDED — — — 384,885 +42,000 +12.2% 0.61% $6.1M 2025-11-04 $14.74
2025 Q2 INITIATED — — — 342,885 — — 0.38% $3.2M 2025-08-08 $10.20

🏢 Other funds also holding BCAX

As of 2026 Q1 — sorted by position size

Red Tree Management, LLC 56.39% Omega Fund Management, LLC 3Y 7Y 29.16% Royalty Pharma Sub-Manager, LLC 26.77% Jones Hill Capital LP 5.37% ACORN CAPITAL ADVISORS, LLC 3.64% Siren, L.L.C. 3.2% Vestal Point Capital, LP 3.02% Aisling Capital Management LP 3Y 7Y 2.38% DAFNA Capital Management LLC 3Y 7Y 1.91% Palo Alto Investors LP 3Y 7Y 1.67%

FAQ About NAN FUNG TRINITY (HK) Ltd and BCAX

These are the practical questions this page is built to answer before you even open the full history table.

How long has NAN FUNG TRINITY (HK) Ltd reported owning BCAX?

NAN FUNG TRINITY (HK) Ltd reported BCAX across 4 quarterly 13F filings, from 2025 Q2 through 2026 Q1.

What was the largest reported BCAX position in NAN FUNG TRINITY (HK) Ltd's portfolio?

The largest reported portfolio weight for BCAX was 0.93% in 2026 Q1.

What is the latest reported BCAX position on this page?

The most recent filing on this page is 2026 Q1, when NAN FUNG TRINITY (HK) Ltd reported 427,885 shares, equal to 0.93% of portfolio, with an estimated market value of $8.5M.

What does the chart on this BCAX ownership page compare?

The chart compares NAN FUNG TRINITY (HK) Ltd's quarterly BCAX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did NAN FUNG TRINITY (HK) Ltd time their BCAX position?

Based on 13F filing dates vs. subsequent BCAX price moves, NAN FUNG TRINITY (HK) Ltd correctly timed 2 out of 3 reported position changes (67%). The annualised alpha on BCAX relative to SPY over the holding period was +291.9%.

← Back to NAN FUNG TRINITY (HK) Ltd Holdings